Original Research From the Recovery Research Institute
Addiction can lead to or worsen many medical conditions, but until now it was not necessarily known if those in recovery from significant alcohol or other drug problems have higher rates of disease than the general U.S. population. The present study shows that in fact they do.
l
It is widely appreciated that the long-term use of alcohol and other drugs gives rise to a wide variety of medical conditions. What is not well understood is to what degree individuals in addiction recovery are affected by disease compared to the general population. In addition to answering these questions, this study also investigated how having medical conditions affected quality of life.
Data from the National Recovery Survey was used in this study. The National Recovery Survey assessed 2,002 U.S. adults who answered yes to the question, “Did you used to have a problem with alcohol or drugs but no longer do?” Participants were asked a number of questions including whether they had ever been told by a healthcare provider if they had 1 or more of 9 medical conditions including alcohol-related liver disease, hepatitis C, tuberculosis (TB), the human immunodeficiency virus (HIV), or acquired immune deficiency syndrome (AIDS), another sexually transmitted infection, chronic obstructive pulmonary disease (COPD), cancer, heart disease, or diabetes. Quality of life was measured using the EUROHIS-QOL—a widely used 8-item measure of quality of life, adapted from the World Health Organization Quality of Life—Brief Version (WHOQOL-BREF).
Where possible, the frequency of specific diseases in the National Recovery Survey sample was compared to the general U.S. population using the Centers for Disease Control Prevention’s, National Health and Nutrition Examination Survey (NHANES) dataset. Comparisons were made using age-standardization; a way of statistically controlling for differences between ages between the two samples.
Relative to the general population, prevalence of hepatitis C, chronic obstructive pulmonary disease (COPD), heart disease, and diabetes were greater in the National Recovery Survey sample. Direct comparison between the National Recovery Survey and NHANES general population datasets was not possible for alcohol-related liver disease, tuberculosis, HIV/AIDS, sexually transmitted infections, and cancer, as the NHANES survey either did not assess for these diseases or assessed them in ways different to the National Recovery Survey.
Though direct comparisons were not possible for these specific diseases, the authors noted that the National Recovery Survey sample experienced rates for these diseases at least comparable with previously reported estimates for the general population, and in some instances, notably greater. For instance, the cancer prevalence rate in the National Recovery Survey sample (5.50%) was slightly higher, but comparable, to estimated prevalence rates in the general population (4.80%). The incidence of HIV/AIDS, however, appears to be 7 to 8 times higher in the National Recovery Survey sample (2.6%), compared with the general population (0.34%), though it is important to note that the Centers for Disease Control Prevention estimates are for 2015 (vs 2016 for the National Recovery Survey sample) and include people aged 13 and older (vs 18 and older for the National Recovery Survey sample). Regarding tuberculosis, 1.42% of this National Recovery Survey sample endorsed being told by a healthcare professional that they have this disease. This is comparable to findings from the 2011 to 2012 NHANES for a positive response to a tuberculosis skin test (1.40%), but higher than the rate of NHANES participants endorsing being told by a healthcare provider that they have active tuberculosis (0.39%), and lower than NHANES participants having a positive tuberculosis blood test (5.82%).
The authors also found that individuals who primarily used classes of drugs commonly associated with injection, such as opiates or stimulants, had higher rates of diseases known to be transmitted by sharing needles, including hepatitis C and HIV.
Participants primarily using stimulants like amphetamines also had higher rates of sexually transmitted infections than those for whom alcohol was primary, which supports previous findings reporting higher incidence of sexually transmitted infections among individuals who use stimulants (particularly methamphetamine) who are believed to engage in greater and/or more risky sexual activity than individuals who don’t use stimulants. Surprisingly, those for whom cannabis was primary were not different in terms of rates of alcohol-related liver disease compared with those for whom alcohol was primary.
Finally, as the authors predicted, quality of life was lower among those with physical disease histories relative to those without.
Figure 1.
In combination with other epidemiological and clinical findings regarding the harmful impact of alcohol and other drug use on health, this study suggests the need for earlier and more assertive intervention to help reduce medical disease burden, and underscores the need for better integration of medical and substance use disorder services.
Such services should include assertive linkage by healthcare providers to comprehensive medical and psychosocial recovery management, given more passive linkage has had limited effect on patient treatment engagement and not shown significant long-term benefit in terms of addiction recovery outcomes. Further longitudinal research is needed that can help uncover the relationships between alcohol and other drug use and the onset of various medical conditions over time. Such research will help us to better understand the time-course of these diseases, both in terms of their onset, persistence and resolution, before, during and after addiction recovery is achieved.
As noted by the authors:
Eddie, D., Greene, M. C., White, W. L., & Kelly, J. F. (In press). Medical burden of disease among individuals in recovery from alcohol and drug problems in the United States: Findings from the National Recovery Survey. Journal of Addiction Medicine.
l
It is widely appreciated that the long-term use of alcohol and other drugs gives rise to a wide variety of medical conditions. What is not well understood is to what degree individuals in addiction recovery are affected by disease compared to the general population. In addition to answering these questions, this study also investigated how having medical conditions affected quality of life.
Data from the National Recovery Survey was used in this study. The National Recovery Survey assessed 2,002 U.S. adults who answered yes to the question, “Did you used to have a problem with alcohol or drugs but no longer do?” Participants were asked a number of questions including whether they had ever been told by a healthcare provider if they had 1 or more of 9 medical conditions including alcohol-related liver disease, hepatitis C, tuberculosis (TB), the human immunodeficiency virus (HIV), or acquired immune deficiency syndrome (AIDS), another sexually transmitted infection, chronic obstructive pulmonary disease (COPD), cancer, heart disease, or diabetes. Quality of life was measured using the EUROHIS-QOL—a widely used 8-item measure of quality of life, adapted from the World Health Organization Quality of Life—Brief Version (WHOQOL-BREF).
Where possible, the frequency of specific diseases in the National Recovery Survey sample was compared to the general U.S. population using the Centers for Disease Control Prevention’s, National Health and Nutrition Examination Survey (NHANES) dataset. Comparisons were made using age-standardization; a way of statistically controlling for differences between ages between the two samples.
Relative to the general population, prevalence of hepatitis C, chronic obstructive pulmonary disease (COPD), heart disease, and diabetes were greater in the National Recovery Survey sample. Direct comparison between the National Recovery Survey and NHANES general population datasets was not possible for alcohol-related liver disease, tuberculosis, HIV/AIDS, sexually transmitted infections, and cancer, as the NHANES survey either did not assess for these diseases or assessed them in ways different to the National Recovery Survey.
Though direct comparisons were not possible for these specific diseases, the authors noted that the National Recovery Survey sample experienced rates for these diseases at least comparable with previously reported estimates for the general population, and in some instances, notably greater. For instance, the cancer prevalence rate in the National Recovery Survey sample (5.50%) was slightly higher, but comparable, to estimated prevalence rates in the general population (4.80%). The incidence of HIV/AIDS, however, appears to be 7 to 8 times higher in the National Recovery Survey sample (2.6%), compared with the general population (0.34%), though it is important to note that the Centers for Disease Control Prevention estimates are for 2015 (vs 2016 for the National Recovery Survey sample) and include people aged 13 and older (vs 18 and older for the National Recovery Survey sample). Regarding tuberculosis, 1.42% of this National Recovery Survey sample endorsed being told by a healthcare professional that they have this disease. This is comparable to findings from the 2011 to 2012 NHANES for a positive response to a tuberculosis skin test (1.40%), but higher than the rate of NHANES participants endorsing being told by a healthcare provider that they have active tuberculosis (0.39%), and lower than NHANES participants having a positive tuberculosis blood test (5.82%).
The authors also found that individuals who primarily used classes of drugs commonly associated with injection, such as opiates or stimulants, had higher rates of diseases known to be transmitted by sharing needles, including hepatitis C and HIV.
Participants primarily using stimulants like amphetamines also had higher rates of sexually transmitted infections than those for whom alcohol was primary, which supports previous findings reporting higher incidence of sexually transmitted infections among individuals who use stimulants (particularly methamphetamine) who are believed to engage in greater and/or more risky sexual activity than individuals who don’t use stimulants. Surprisingly, those for whom cannabis was primary were not different in terms of rates of alcohol-related liver disease compared with those for whom alcohol was primary.
Finally, as the authors predicted, quality of life was lower among those with physical disease histories relative to those without.
Figure 1.
In combination with other epidemiological and clinical findings regarding the harmful impact of alcohol and other drug use on health, this study suggests the need for earlier and more assertive intervention to help reduce medical disease burden, and underscores the need for better integration of medical and substance use disorder services.
Such services should include assertive linkage by healthcare providers to comprehensive medical and psychosocial recovery management, given more passive linkage has had limited effect on patient treatment engagement and not shown significant long-term benefit in terms of addiction recovery outcomes. Further longitudinal research is needed that can help uncover the relationships between alcohol and other drug use and the onset of various medical conditions over time. Such research will help us to better understand the time-course of these diseases, both in terms of their onset, persistence and resolution, before, during and after addiction recovery is achieved.
As noted by the authors:
Eddie, D., Greene, M. C., White, W. L., & Kelly, J. F. (In press). Medical burden of disease among individuals in recovery from alcohol and drug problems in the United States: Findings from the National Recovery Survey. Journal of Addiction Medicine.
l
It is widely appreciated that the long-term use of alcohol and other drugs gives rise to a wide variety of medical conditions. What is not well understood is to what degree individuals in addiction recovery are affected by disease compared to the general population. In addition to answering these questions, this study also investigated how having medical conditions affected quality of life.
Data from the National Recovery Survey was used in this study. The National Recovery Survey assessed 2,002 U.S. adults who answered yes to the question, “Did you used to have a problem with alcohol or drugs but no longer do?” Participants were asked a number of questions including whether they had ever been told by a healthcare provider if they had 1 or more of 9 medical conditions including alcohol-related liver disease, hepatitis C, tuberculosis (TB), the human immunodeficiency virus (HIV), or acquired immune deficiency syndrome (AIDS), another sexually transmitted infection, chronic obstructive pulmonary disease (COPD), cancer, heart disease, or diabetes. Quality of life was measured using the EUROHIS-QOL—a widely used 8-item measure of quality of life, adapted from the World Health Organization Quality of Life—Brief Version (WHOQOL-BREF).
Where possible, the frequency of specific diseases in the National Recovery Survey sample was compared to the general U.S. population using the Centers for Disease Control Prevention’s, National Health and Nutrition Examination Survey (NHANES) dataset. Comparisons were made using age-standardization; a way of statistically controlling for differences between ages between the two samples.
Relative to the general population, prevalence of hepatitis C, chronic obstructive pulmonary disease (COPD), heart disease, and diabetes were greater in the National Recovery Survey sample. Direct comparison between the National Recovery Survey and NHANES general population datasets was not possible for alcohol-related liver disease, tuberculosis, HIV/AIDS, sexually transmitted infections, and cancer, as the NHANES survey either did not assess for these diseases or assessed them in ways different to the National Recovery Survey.
Though direct comparisons were not possible for these specific diseases, the authors noted that the National Recovery Survey sample experienced rates for these diseases at least comparable with previously reported estimates for the general population, and in some instances, notably greater. For instance, the cancer prevalence rate in the National Recovery Survey sample (5.50%) was slightly higher, but comparable, to estimated prevalence rates in the general population (4.80%). The incidence of HIV/AIDS, however, appears to be 7 to 8 times higher in the National Recovery Survey sample (2.6%), compared with the general population (0.34%), though it is important to note that the Centers for Disease Control Prevention estimates are for 2015 (vs 2016 for the National Recovery Survey sample) and include people aged 13 and older (vs 18 and older for the National Recovery Survey sample). Regarding tuberculosis, 1.42% of this National Recovery Survey sample endorsed being told by a healthcare professional that they have this disease. This is comparable to findings from the 2011 to 2012 NHANES for a positive response to a tuberculosis skin test (1.40%), but higher than the rate of NHANES participants endorsing being told by a healthcare provider that they have active tuberculosis (0.39%), and lower than NHANES participants having a positive tuberculosis blood test (5.82%).
The authors also found that individuals who primarily used classes of drugs commonly associated with injection, such as opiates or stimulants, had higher rates of diseases known to be transmitted by sharing needles, including hepatitis C and HIV.
Participants primarily using stimulants like amphetamines also had higher rates of sexually transmitted infections than those for whom alcohol was primary, which supports previous findings reporting higher incidence of sexually transmitted infections among individuals who use stimulants (particularly methamphetamine) who are believed to engage in greater and/or more risky sexual activity than individuals who don’t use stimulants. Surprisingly, those for whom cannabis was primary were not different in terms of rates of alcohol-related liver disease compared with those for whom alcohol was primary.
Finally, as the authors predicted, quality of life was lower among those with physical disease histories relative to those without.
Figure 1.
In combination with other epidemiological and clinical findings regarding the harmful impact of alcohol and other drug use on health, this study suggests the need for earlier and more assertive intervention to help reduce medical disease burden, and underscores the need for better integration of medical and substance use disorder services.
Such services should include assertive linkage by healthcare providers to comprehensive medical and psychosocial recovery management, given more passive linkage has had limited effect on patient treatment engagement and not shown significant long-term benefit in terms of addiction recovery outcomes. Further longitudinal research is needed that can help uncover the relationships between alcohol and other drug use and the onset of various medical conditions over time. Such research will help us to better understand the time-course of these diseases, both in terms of their onset, persistence and resolution, before, during and after addiction recovery is achieved.
As noted by the authors:
Eddie, D., Greene, M. C., White, W. L., & Kelly, J. F. (In press). Medical burden of disease among individuals in recovery from alcohol and drug problems in the United States: Findings from the National Recovery Survey. Journal of Addiction Medicine.
SIGN UP FOR THE BULLETIN
